Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rein Therapeutics (RNTX) Treasury Shares (2019 - 2021)

Rein Therapeutics (RNTX) has disclosed Treasury Shares for 3 consecutive years, with $250000.0 as the latest value for Q1 2021.

  • On a quarterly basis, Treasury Shares rose 400.0% to $250000.0 in Q1 2021 year-over-year; TTM through Mar 2021 was $250000.0, a 400.0% increase, with the full-year FY2019 number at $50000.0, changed N/A from a year prior.
  • Treasury Shares was $250000.0 for Q1 2021 at Rein Therapeutics, up from $10000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $250000.0 in Q1 2021 to a low of $10000.0 in Q2 2020.
  • A 3-year average of $76666.7 and a median of $50000.0 in 2019 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: crashed 80.0% in 2020, then surged 400.0% in 2021.
  • Rein Therapeutics' Treasury Shares stood at $50000.0 in 2019, then plummeted by 80.0% to $10000.0 in 2020, then skyrocketed by 2400.0% to $250000.0 in 2021.
  • Per Business Quant, the three most recent readings for RNTX's Treasury Shares are $250000.0 (Q1 2021), $10000.0 (Q2 2020), and $50000.0 (Q1 2020).